Haemonetics (HAE) to acquire Vivasure Medical Limited for 100 million euros upfront plus potential milestone payments.

Residents of the Coachella Valley and Inland Empire living with chronic knee pain caused by osteoarthritis now have access to a minimally invasive alternative to knee replacement surgery. Empire Vein ...

Boston Scientific Corporation (NYSE: BSX) and Penumbra, Inc., (NYSE: PEN) today announced the companies have entered into a ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

Together, they aim to enhance clinical capabilities, provide expanded specialty services and streamline access to leading ...

The New York State Department of Health has given the go-ahead for $53 million worth of construction projects at Memorial ...

Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical ...

Haemonetics' acquisition of Vivasure adds PerQseal Elite, advancing large-bore closure solutions for TAVR and EVAR markets.

The sixth round of China's centralized procurement program for high-value medical consumables, targeting 12 types of ...

Sharon Regional Health System and Independence Health System are coming together to bring patients enhanced clinical ...